AS
REGN icon

Aware Super’s Regeneron Pharmaceuticals REGN Stock Holding History

Aware Super’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.94M Buy
+3,803
New +$2.91M 0.04% 194
2025
Q3 		$634K Hold
1,128
– – 0.01% 220
2025
Q2 		$592K Sell
1,128
-1,949
-63% -$1.09M 0.01% 224
2025
Q1 		$1.95M Hold
3,077
– – 0.03% 211
2024
Q4 		$2.19M Buy
+3,077
New +$2.58M 0.04% 208
2023
Q4 		$3.08M Buy
+3,995
New +$3.29M 0.04% 197

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Aware Super's REGN Position: Q1 2026 in Review

Aware Super opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2026: 3,803 shares worth $2.94M. The stake represents 0.04% of the portfolio and ranks #194 among its holdings. This is a return to the name: Aware Super previously reported a position in REGN as recently as Q3 2025.

Aware Super first reported a position in REGN in Q4 2023 and has held it in 6 quarters since. The position peaked at $3.08M in Q4 2023. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Aware Super held 3,803 shares of Regeneron Pharmaceuticals worth $2.94M as of Q1 2026.
  • Regeneron Pharmaceuticals was a new Aware Super position in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.04% of Aware Super's portfolio in Q1 2026, its #194 holding.
  • Aware Super first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • Aware Super's Regeneron Pharmaceuticals position peaked at $3.08M in Q4 2023.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Aware Super's 13F filing for Q1 2026, filed 5 May 2026.